1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
3
|
Mungan I, Dicle ÇB, Bektas S, Sari S,
Yamanyar S, Çavuş M, Turan S and Bostanci EB: Does the preoperative
platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio
predict morbidity after gastrectomy for gastric cancer? Mil Med
Res. 7:42020.PubMed/NCBI
|
4
|
Hamilton TD, Mahar AL, Haas B, Beyfuss K,
Law CHL, Karanicolas PJ, Coburn NG and Hallet J: The impact of
advanced age on short-term outcomes following gastric cancer
resection: An ACS-NSQIP analysis. Gastric Cancer. 21:710–719. 2018.
View Article : Google Scholar : PubMed/NCBI
|
5
|
Balea AM, Cruce R, Schenker RA, Ionescu
AG, Streba L, Ciurea AM, Ghilusi MC, Pirici D and Vere CE:
Correlations between clinicopathological features and the
vegetative nervous system in gastric cancer. Curr Health Sci J.
45:351–357. 2019.PubMed/NCBI
|
6
|
Zong L, Abe M, Seto Y and Ji J: The
challenge of screening for early gastric cancer in China. Lancet.
388:26062016. View Article : Google Scholar : PubMed/NCBI
|
7
|
Yao J, Zhang H, Liu C, Chen S, Qian R and
Zhao K: MiR-450b-3p inhibited the proliferation of gastric cancer
via regulating KLF7. Cancer Cell Int. 20:472020. View Article : Google Scholar : PubMed/NCBI
|
8
|
Liu J, Liu T, Wang X and He A: Circles
reshaping the RNA world: From waste to treasure. Mol Cancer.
16:582017. View Article : Google Scholar : PubMed/NCBI
|
9
|
Huang HS, Huang XY, Yu HZ, Xue Y and Zhu
PL: Circular RNA circ-RELL1 regulates inflammatory response by
miR-6873-3p/MyD88/NF-κB axis in endothelial cells. Biochem Biophys
Res Commun. 30:512–519. 2020. View Article : Google Scholar
|
10
|
Meng S, Zhou H, Feng Z, Xu Z, Tang Y, Li P
and Wu M: CircRNA: Functions and properties of a novel potential
biomarker for cancer. Mol Cancer. 16:942017. View Article : Google Scholar : PubMed/NCBI
|
11
|
Wang S, Zhang Y, Cai Q, Ma M, Jin LY, Weng
M, Zhou D, Tang Z, Wang JD and Quan Z: Circular RNA FOXP1 promotes
tumor progression and warburg effect in gallbladder cancer by
regulating PKLR expression. Mol Cancer. 18:1452019. View Article : Google Scholar : PubMed/NCBI
|
12
|
Yan L, Zheng M and Wang H: Circular RNA
hsa_circ_0072309 inhibits proliferation and invasion of breast
cancer cells via targeting miR-492. Cancer Manag Res. 11:1033–1041.
2019. View Article : Google Scholar : PubMed/NCBI
|
13
|
Chen T, Shao S, Li W, Liu Y and Cao Y: The
circular RNA hsa-circ-0072309 plays anti-tumour roles by sponging
miR-100 through the deactivation of PI3K/AKT and mTOR pathways in
the renal carcinoma cell lines. Artif Cells Nanomed Biotechnol.
47:3638–3648. 2019. View Article : Google Scholar : PubMed/NCBI
|
14
|
Sharifi A, Vahedi H, Honarvar MR, Amiriani
T, Nikniaz Z, Rad EY and Hosseinzadeh-Attar MJ: Vitamin D decreases
CD40L gene expression in ulcerative colitis patients: A randomized,
double-blinded, placebo-controlled trial. Turk J Gastroenterol.
31:99–104. 2020. View Article : Google Scholar : PubMed/NCBI
|
15
|
Wan B, Liu B and Lv C: Progress of
research into circular RNAs in urinary neoplasms. PeerJ.
8:e86662020. View Article : Google Scholar : PubMed/NCBI
|
16
|
Su Y, Feng W, Shi J, Chen L, Huang J and
Lin T: circRIP2 accelerates bladder cancer progression via
miR-1305/Tgf-β2/smad3 pathway. Mol Cancer. 19:232020. View Article : Google Scholar : PubMed/NCBI
|
17
|
Yao J, Xu G, Zhu L and Zheng H:
circGFRA1enhances NSCLC progression by sponging miR-188-3p. Onco
Targets Ther. 13:549–558. 2020. View Article : Google Scholar : PubMed/NCBI
|
18
|
Li Z, Ruan Y, Zhang H, Shen Y, Li T and
Xiao B: Tumor-Suppressive circular RNAs: Mechanisms underlying
their suppression of tumor occurrence and use as therapeutic
targets. Cancer Sci. 110:3630–3638. 2019. View Article : Google Scholar : PubMed/NCBI
|
19
|
Huang Q, Huang QY, Sun Y and Wu S:
High-Throughput data reveals novel circular RNAs via competitive
endogenous RNA networks associated with human intracranial
aneurysms. Med Sci Monit. 25:4819–4830. 2019. View Article : Google Scholar : PubMed/NCBI
|
20
|
de Biase D, Visani M, Pession A and
Tallini G: Molecular diagnosis of carcinomas of the thyroid gland.
Front Biosci (Elite Ed). 6:1–14. 2014.PubMed/NCBI
|
21
|
Yousefi B, Azimi A, Majidinia M,
Shafiei-Irannejad V, Badalzadeh R, Baradaran B, Zarghami N and
Samadi N: Balaglitazone reverses P-glycoprotein-mediated multidrug
resistance via upregulation of PTEN in a PPARgamma-dependent manner
in leukemia cells. Tumour Biol. 39:10104283177165012017. View Article : Google Scholar : PubMed/NCBI
|
22
|
Jiang J, Zhang Y, Yu C, Li Z, Pan Y and
Sun C: MicroRNA-492 expression promotes the progression of hepatic
cancer by targeting PTEN. Cancer Cell Int. 14:952014. View Article : Google Scholar : PubMed/NCBI
|
23
|
Hyun S, Kim MS, Song YS, Bak Y, Ham SY,
Lee DH, Hong J and Yoon DY: Peroxisome proliferator-activated
receptor-gamma agonist 4-O-methylhonokiol induces apoptosis by
triggering the intrinsic apoptosis pathway and inhibiting the
PI3K/Akt survival pathway in SiHa human cervical cancer cells. J
Microbiol Biotechnol. 25:334–342. 2015. View Article : Google Scholar : PubMed/NCBI
|
24
|
Lv S, Wang W, Wang H, Zhu Y and Lei C:
PPARγ activation serves as therapeutic strategy against bladder
cancer via inhibiting PI3K-Akt signaling pathway. BMC Cancer.
19:2042019. View Article : Google Scholar : PubMed/NCBI
|
25
|
Esmaeili S, Safaroghli-Azar A,
Pourbagheri-Sigaroodi A, Salari S, Gharehbaghian A, Hamidpour M and
Bashash D: Stimulation of peroxisome proliferator-activated
receptor-gamma (PPARγ) using pioglitazone decreases the survival of
acute promyelocytic leukemia cells through up-regulation of PTEN
expression. Anticancer Agents Med Chem. 21:108–119. 2021.
View Article : Google Scholar : PubMed/NCBI
|